Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Breast Cancer Virtual Meeting 2020

ESMO Breast Cancer Virtual Meeting 2020: Industry Sponsored Satellite Symposia

ESMO-Breast-Cancer-Virtual-Meeting-1000x250

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer 

Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer Thumb

View the satellite invitation

A New Decade in the Evolving Treatment Landscape for HER2 Positive Metastatic Breast Cancer 

A-New-Decade-in-the-Evolving-Treatment-Landscape-for-HER2-Positive-Metastatic-Breast-Cancer-DAIICHI-SANKYO-Thumb

View the satellite invitation

Debate: In the Modern Management of HER2-HR+MBC, Should Chemotherapy be the Treatment of Last Resort?

Debate-in-the-Modern-Management-of-HER2-HR+MBC-Should-Chemotherapy-be-the-Treatment-of-Last-Resort-EISAI-Thumb

View the satellite invitation

The Power of Choice in HR+, HER2- Advanced Breast Cancer: A Case Continuum

The-Power-of-Choice-in-HR+-HER2-Advanced-Breast-Cancer-A-Case-Continuum-NOVARTIS-Thumb

View the satellite invitation

The Evolving Treatment Landscape of Early Triple Negative Breast Cancer

The-Evolving-Treatment-Landscape-of-Early-Triple-Negative-Breast-Cancer-MSD-Thumb

View the satellite invitation

Optimising Breast Cancer Outcomes: Clinical and Real-World Experience Lead to Strength in numbers

Optimising-breast-cancer-outcomes-Clinical-and-real-world-experience-lead-to-strength-in-numbers-PFIZER-Thumb

View the satellite invitation

How to do More to Improve HER2-positive Early Breast Cancer Patient Outcomes?

How-to-do-more-to-improve-HER2-positive-early-breast-cancer-patient-outcomes-PIERRE-FABRE-Thumb

View the satellite invitation

Improving Outcomes After T-DM1: A New Horizon for HER2+ mBC Patients 

Improving-Outcomes-After-T-DM1-A-A-New-Horizon-for-HER2+-mBC-Patients-SEATTLE-GENETICS-Thumbs

View the satellite invitation

Bringing Molecular Insights to The Clinic: Recent Advances in Breast Cancer Treatment

Bringing-Molecular-Insights-to-The-Clinic-Recent-Advances-in-Breast-Cancer-Treatment-ROCHE-Thumb

View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

Meeting Resources

Access all the resources published by industry partners.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.